FDA Inspection
Cohance Lifesciences LimitedCohance Lifesciences Limited – FDA Inspection, Jul 12, 2016
Record Details
This FDA Inspection record concerns Cohance Lifesciences Limited, with an inspection on July 12, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Cohance Lifesciences Limited
- Inspection Date
- July 12, 2016
- Product Type
- Drugs
View Company Profile
ID · 6cbde5a0-c889-4361-ab5c-95561011d520
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 980924
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Cohance Lifesciences Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 12, 2025 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| August 20, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 11, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cohance Lifesciences Limited
- FDA Inspection 1278348 - 2025-08-12
- FDA Inspection 1100953 - 2019-08-20
- FDA Inspection 1040233 - 2018-02-06
- FDA Inspection 853289 - 2013-10-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.